Cano-Contreras AD, Duran-Rosas C, Fernández-Martínez NC, Sánchez-Martínez R, Barrientos-Olvera J, Juárez-Valdés EI, Mejía-Loza SMI, García-Ruíz E, Pérez-y López N, Zamarripa-Dorsey F

Language: Spanish
References: 15
Page: 125-129
PDF size: 136.83 Kb.

ABSTRACT

Introduction: Health workers are a high-risk group for Hepatitis C virus (HCV) infection. In Mexico, prevalence of this virus reaches 1.4% in general and 1.3% among health workers. Objective: To determine the prevalence of seropositivity for hepatitis C virus antibodies among health workers from Hospital Juarez de Mexico. Material and methods: Prospective, observational, longitudinal and descriptive study carried out on health workers at the Juarez Hospital in Mexico who did not know serological diagnosis and voluntarily agreed to answer a survey on risk factors as well as serological determination of anti-HCV by immunoenzymatic assay, if positive, antibodies were confirmed by recombinant HCV specific antigens with enzymatic immunoassay by strip immunoblot technique. The analysis of the results was carried out by means of descriptive statistics with the statistical program SPSS v22. Results: Three hundred and forty-one health workers agreed to participate. We analyzed 317 workers, 131 (40.2%) women aged 37.9 ± 11.9 years, with 13.2 ± 11.1 years of work experience. Two hundred and eight (65.4%) reported contact with HCV patients and 122 (38.4%) had HCV screening. The main risk factor reported was history of surgery in 175 (55%). Four samples (1.2%) were reactive to anti-HCV with an average positive S/CO value of 2.4200, confirmed positive result, age 55.7 ± 17.4 years (33 to 74), 30.5 ± 15.8 years of work experience, 3 (47%) men, 2 (50%) physicians from the surgical area and 2 (50%) others. The risk factors reported were: contact with patients with HCV 2 (50%), acupuncture 2 (50%), tattoos 2 (50%), more than 4 sexual partners 2 (50%), accidental injuries with hemocontaminated objects 1 (25%), surgeries 1 (25%) and blood transfusions 1 (25%). Conclusion: The results of our study show prevalence of anti-HCV similar to that reported in the open population of our country, despite being a high-risk population, this translates into the success of protective measures. We believe that timely detection should be promoted in high-risk populations, as our study showed that 61.3% had never been tested serologically.

REFERENCES

1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl): S45-57.

2. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015; 15(7): 819-24.

3. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67.

4. Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014 (http:// apps.who.int/iris/bitstream/10665/111747/1/9789241548755_ eng.pdf?ua=1&ua=1, accessed 18 December 2015).

5. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014; 59(6): 765-73.

6. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010; 14(11): E928-40.

7. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42.

8. Gerberding GL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis. 1994; 170: 1410-7.

9. Martínez JD, Garzón MA, Arteaga JM, Hernandez G, Manrique C, Hormaza N, et al. Determinacion de la prevalencia de hepatitis C mediante prueba rápida BIOLINE HCV en una población de alto riesgo. Rev Col Gastroenterol. 2015; 30(3): 273-8.

10. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl): S45-57.

11. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, México: Instituto Nacional de Salud Pública, 2003.

12. Santos-López G, Sosa-Jurado F, Vallejo-Ruiz V, et al. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect. 2008; 56: 281-90.

13. González HM, Sánchez HE, Camacho MC, Rebollo V. Prevalencia de marcadores positivos para hepatitis B (Ags-VHB) y hepatitis C (anti-VHC) en personal de salud del ISSEMYM. Rev Gastroenterol Mex. 2010; 3(75): 293-8.

14. Chiquete E, Panduro A. Low Prevalence of anti-Hepatitis C virus antibodies in México: a systematic review. Intervirology. 2007; 50: 1-8.

15. MacCannell T, Laramie AK, Gomaa A, et al. Occupational exposure of health care personnel to hepatitis B and hepatitis C: prevention and surveillance strategies. Clin Liver Dis. 2010; 14: 23-36.